RT Journal Article
SR Electronic
T1 274 Development of CTX112 a next generation allogeneic multiplexed CRISPR-edited CART cell therapy with disruptions of the TGFBR2 and Regnase-1 genes for improved manufacturing and potency
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A314
OP A314
DO 10.1136/jitc-2023-SITC2023.0274
VO 11
IS Suppl 1
A1 Kalaitzidis, Demetrios
A1 Ghonime, Mohammed
A1 Chain, Robert
A1 Jaishankar, Nivedita
A1 Settipane, Davis
A1 Padalia, Zinkal
A1 Zakas, Lauren
A1 Kuppuraju, Meghna
A1 Tetteh, Paul
A1 Dequeant, Mary-Lee
A1 Karnik, Sushant
A1 Massilamany, Chandirasegaran
A1 McEwan, Brigid
A1 Dar, Henia
A1 Allen, Melanie
A1 Serwer, Laura
A1 Nguyen, Thao
A1 Butler-Gauthier, Melanie
A1 Sripakdeevong, Parin
A1 Nagar, Shashwat
A1 Tang, Yin
A1 Flanagan, Nicole
A1 Huang, Elaine
A1 Phuyal, Shashwant
A1 Dunn, Andrew
A1 Koch, Elizabeth
A1 Sula, Erisa
A1 Waldman, Jacob
A1 Zhang, Maria Lei
A1 Loaiza, Cristian
A1 Thorstensen, Erin
A1 Steiger, Keith
A1 Schum, Katie
A1 Urbaez, Kayla
A1 Ma, Anna
A1 Weaver, Annie Yang
A1 Finch, Christopher
A1 Cohen, Sarah
A1 Morrow, PK
A1 Benton, Mark
A1 Terrett, Jonathan
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A314.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.